# Novartis Pharma AG, Basel, Switzerland – FDA Inspections

Source: https://www.keypedia.com/companies/novartis-pharma-ag/194ac641-5956-4430-9641-411cb975a51f

> Inspection records and compliance data for Novartis Pharma AG in Basel. 11 FDA inspections on record, 2 Form 483s, last inspected August 30, 2022.

---

## Details

- Name: Novartis Pharma AG
- FEI Number: 3002807772
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING
- Address Line 1: Lichtstrasse 35
- City: Basel
- Country Name: Switzerland
- Address: Lichtstrasse 35, Basel, Switzerland
- Country: Switzerland

## Related Documents

- [483 - Novartis Pharma AG - 2022-08-30](https://www.keypedia.com/records/483/novartis-pharma-ag/7020c2fe-862b-4517-b28a-f6b34cd39f2d) — source: FDA, date: August 30, 2022
- FDA Inspection 1180833 - Novartis Pharma AG - 2022-08-30 — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 30, 2022
- [FDA Inspection 1109986 - Novartis Pharma AG - 2019-08-29](https://www.keypedia.com/records/fda_inspections/novartis-pharma-ag/0857ce8e-6530-4997-b440-9f2dae82399a) — source: FDA, date: August 29, 2019
- FDA Inspection 1099919 - Novartis Pharma AG - 2019-07-12 — classification: No Action Indicated (NAI), source: FDA, date: July 12, 2019
- FDA Inspection 1053787 - Novartis Pharma AG - 2018-04-20 — source: FDA, date: April 20, 2018
- [FDA Inspection 1021086 - Novartis Pharma AG - 2017-07-06](https://www.keypedia.com/records/fda_inspections/novartis-pharma-ag/25132932-baad-4786-893f-6aa8f8fa697b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 6, 2017
- FDA Inspection 916149 - Novartis Pharma AG - 2015-01-14 — classification: No Action Indicated (NAI), source: FDA, date: January 14, 2015
- FDA Inspection 861652 - Novartis Pharma AG - 2013-12-05 — classification: No Action Indicated (NAI), source: FDA, date: December 5, 2013
- FDA Inspection 793862 - Novartis Pharma AG - 2012-07-26 — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 26, 2012
- FDA Inspection 794636 - Novartis Pharma AG - 2012-07-18 — classification: No Action Indicated (NAI), source: FDA, date: July 18, 2012
- FDA Inspection 557727 - Novartis Pharma AG - 2008-11-21 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 21, 2008

## Related Companies

- [SigmaPharm Laboratories LLC](https://www.keypedia.com/companies/sigmapharm-laboratories-llc/f300f462-6d27-47a8-842b-031dbdeed07b)
- [Fresenius Kabi Austria Gmbh](https://www.keypedia.com/companies/fresenius-kabi-austria-gmbh/f0cc0bbb-a42b-4b48-9334-0426fb359254)
- [Astellas Pharma Inc.](https://www.keypedia.com/companies/astellas-pharma-inc/9a5bc049-426d-4313-b8b8-1ce28d48fa42)
- [Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd](https://www.keypedia.com/companies/hangzhou-zhongmei-huadong-pharmaceutical-co-ltd/484385fe-e88b-4fbd-a58d-4759ca816ab9)
- [Sun Pharmaceutical Industries Limited](https://www.keypedia.com/companies/sun-pharmaceutical-industries-limited/51c5d6b8-303e-4e32-bbef-eaca05e879ef)
- [Amgen Singapore Manufacturing Pte Ltd](https://www.keypedia.com/companies/amgen-singapore-manufacturing-pte-ltd/ff869a15-a7c2-441a-8165-7fd77928331e)
- [Hovione FarmaCiencia SA](https://www.keypedia.com/companies/hovione-farmaciencia-sa/e55a2dd8-7c1c-493d-8511-9761732d75ec)
- [Genzyme Flanders](https://www.keypedia.com/companies/genzyme-flanders/5f71d574-8097-4cd8-9254-2f8b85700e59)
- [Asymchem Life Science (Tianjin) Co., Ltd.](https://www.keypedia.com/companies/asymchem-life-science-tianjin-co-ltd/ccb993d1-42a4-40fe-9c05-bf590f287eeb)
- [Vistin Pharma AS avd Kragero Fikkjebakke](https://www.keypedia.com/companies/vistin-pharma-as-avd-kragero-fikkjebakke/6acc0a66-9192-481c-a1bf-4d4d0cbf68e7)

## Related Officers

- [Compliance Officer](https://www.keypedia.com/people/yasamin-ameri/73021772-c960-4c65-aa30-cb490866ee58)